Join the Campaign

Specialty Pharmacy

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
October 10, 2017
October 10, 2017
Bevacizumab won FDA approval for treatment of advanced cervical cancer based on preliminary trial evidence and now, 3 years later, final analysis of...
Bevacizumab won FDA approval for treatment of advanced cervical cancer based on preliminary trial evidence and now, 3 years later, final analysis of the study results has been completed. The Phase III investigation, which opened enrollment in early 2009, randomized participants into one of four arms: I.V.
MORE
September 29, 2017
September 29, 2017
FDA approved on September 28 abemaciclib (Verzenio—Eli Lilly) for the treatment of adults who have hormone receptor (HR)-positive, human epidermal...
FDA approved on September 28 abemaciclib (Verzenio—Eli Lilly) for the treatment of adults who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking endocrine therapy.
MORE
September 25, 2017
September 25, 2017
Express Scripts has criticized the $475,000 price tag on Novartis AG's latest breakthrough cancer therapy. The cost of the leukemia treatment—...
Express Scripts has criticized the $475,000 price tag on Novartis AG's latest breakthrough cancer therapy.
MORE
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
October 17, 2017
October 17, 2017
APhA Executive Vice President and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, testified in a hearing about drug prices held by the...
Gag clauses, lack of provider status hinder cost-effective care, importation is no solution, APhA CEO says
MORE
August 14, 2017
August 14, 2017
Tennessee saw major provider status legislation take effect on July 1. “Pharmacists as Providers” (HB 405/SB 461) gives Tennessee pharmacists formal...
‘Pharmacists as providers’ legislation went into effect July 1
MORE
July 13, 2017
July 13, 2017
The Massachusetts Senate and House of Representatives health care committee held a hearing on legislation that would expand the scope of practice...
Hearing held last month included testimony from pharmacists and physicians
MORE
Advertisement